首页> 美国卫生研究院文献>International Journal of Vascular Medicine >Local Intracoronary Eptifibatide versus Mechanical Aspiration in Patients with Acute ST-Elevation Myocardial Infarction
【2h】

Local Intracoronary Eptifibatide versus Mechanical Aspiration in Patients with Acute ST-Elevation Myocardial Infarction

机译:急性ST段抬高型心肌梗死患者局部冠脉内依替非巴肽与机械抽吸的关系

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objectives. We compared local delivery of intracoronary eptifibatide via perfusion catheter to thrombus aspiration in primary PCI. Background. Perfusion catheter increases local concentration of the drugs at the culprit site and prolongs their residency time. Methods. 75 patients with acute STEMI were randomized to three groups: 25 received local intracoronary eptifibatide and verapamil via perfusion catheter; 25 patients were managed by Diver CE thrombectomy device and 25 patients by primary PCI without thrombus aspiration. Primary end point was assessment of postprocedural TIMI flow, MPG, and corrected TIMI frame count (cTFC) in the culprit vessel. Results. Perfusion catheter was superior to thrombus aspiration and conventional PCI as regards MBG (68% versus 36% in Diver CE and 20% in the control arm; P value = 0.002), with shorter cTFC rates than thrombectomy and control groups (20.76 ± 4.44 versus 26.68 ± 8.40 and 28.16 ± 5.96, resp.; P = 0.001). TIMI flow was not different between the 3 groups. Eptifibatide led to less time to peak CK (13.12 hours versus 16.5 and 19.5 hours, respectively, P value = 0.001). Conclusion. Local intracoronary eptifibatide by perfusion catheter reduces thrombus burden with better results in microvascular perfusion assessed by cTFC and MBG compared to aspiration device or conventional PCI.
机译:目标。我们比较了通过灌注导管局部输注冠状动脉内埃替非巴肽与原发性PCI中的血栓抽吸。背景。灌注导管会增加罪犯部位的局部药物浓度,并延长其驻留时间。方法。将75例急性STEMI患者随机分为三组:25例通过灌注导管接受局部冠状动脉内埃替非巴肽和维拉帕米治疗;其余25例接受局部治疗。 25例患者采用Diver CE血栓切除术治疗,而25例患者经原发PCI治疗,无血栓抽吸。主要终点是对罪犯血管中术后TIMI流量,MPG和校正的TIMI帧数(cTFC)的评估。结果。在MBG方面,灌注导管优于血栓抽吸术和常规PCI(在Diver CE中为68%,在Diver CE中为36%,在对照组中为20%; P值= 0.002),其cTFC率短于血栓切除术和对照组(20.76±4.44vs。 26.68±8.40和28.16±5.96,分别; P = 0.001)。 3组之间的TIMI流量无差异。依替巴肽导致CK达到峰值的时间更少(分别为13.12小时和16.5和19.5小时,P值= 0.001)。结论。与抽吸装置或常规PCI相比,通过灌注导管进行的局部冠状动脉内eptibatide减少了血栓负担,通过cTFC和MBG评估的微血管灌注效果更好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号